106 related articles for article (PubMed ID: 19272835)
1. Influenza virus shedding: excretion patterns and effects of antiviral treatment.
Aoki FY; Boivin G
J Clin Virol; 2009 Apr; 44(4):255-61. PubMed ID: 19272835
[No Abstract] [Full Text] [Related]
2. Prolonged influenza virus infection during lymphocytopenia and frequent detection of drug-resistant viruses.
Gooskens J; Jonges M; Claas EC; Meijer A; Kroes AC
J Infect Dis; 2009 May; 199(10):1435-41. PubMed ID: 19392620
[TBL] [Abstract][Full Text] [Related]
3. Implications of antiviral resistance of influenza viruses.
Monto AS
Clin Infect Dis; 2009 Feb; 48(4):397-9. PubMed ID: 19586376
[No Abstract] [Full Text] [Related]
4. Antiviral therapy and outcomes in hospitalized patients with influenza.
Chan-Tack KM; Murray JS
Clin Infect Dis; 2008 May; 46(10):1628-9; author reply 1629-30. PubMed ID: 18419504
[No Abstract] [Full Text] [Related]
5. Antiviral treatment for patients hospitalized with severe influenza infection may affect clinical outcomes.
Lee N; Cockram CS; Chan PK; Hui DS; Choi KW; Sung JJ
Clin Infect Dis; 2008 Apr; 46(8):1323-4. PubMed ID: 18444878
[No Abstract] [Full Text] [Related]
6. Oseltamivir (Tamiflu) for pandemic influenza in India: some issues.
Singh AA
Natl Med J India; 2009; 22(2):103. PubMed ID: 19852352
[No Abstract] [Full Text] [Related]
7. Emerging issues. Agency answers questions about H1N1 flu treatment.
AIDS Policy Law; 2009 Oct; 24(11):4. PubMed ID: 19911486
[No Abstract] [Full Text] [Related]
8. [Therapeutic effects of anti-influenza drugs].
Ikematsu H
Fukuoka Igaku Zasshi; 2007 Nov; 98(11):406-7. PubMed ID: 18286736
[No Abstract] [Full Text] [Related]
9. Human infection with highly pathogenic avian influenza A (H5N1) virus: review of clinical issues.
Uyeki TM
Clin Infect Dis; 2009 Jul; 49(2):279-90. PubMed ID: 19522652
[TBL] [Abstract][Full Text] [Related]
10. Treatment of influenza.
Temte JL
J Fam Pract; 2000 Jan; 49(1):81-2. PubMed ID: 10678349
[No Abstract] [Full Text] [Related]
11. [Use of Tamiflu under pandemic conditions].
Nau JY
Rev Med Suisse; 2009 Jul; 5(211):1532. PubMed ID: 19694366
[No Abstract] [Full Text] [Related]
12. [The therapeutic effectiveness of IZAVR-2 in influenza].
Zlydnikov DM; Romanov IuA; Korotkov VN; Padalko IuV
Vrach Delo; 1972 Sep; 9():142-4. PubMed ID: 4658101
[No Abstract] [Full Text] [Related]
13. [Frequently asked questions concerning the A/H1N1 virus].
Centre d'Information Pharmaceutique, CDSP
J Pharm Belg; 2009 Sep; (3):75-8. PubMed ID: 19873846
[No Abstract] [Full Text] [Related]
14. [Chemoprevention and chemotherapy of influenza and other virus diseases (review of the problem)].
Zlydnikov DM
Ter Arkh; 1972 Mar; 44(3):16-20. PubMed ID: 5027941
[No Abstract] [Full Text] [Related]
15. Swine flu outbreak. What role for antiviral drugs?
Couzin-Frankel J
Science; 2009 May; 324(5928):705. PubMed ID: 19423784
[No Abstract] [Full Text] [Related]
16. Q&A on H1N1 for people with HIV/AIDS. Drug-drug reactions not clear, should be reported.
AIDS Alert; 2009 Jun; 24(6):65-7. PubMed ID: 19544606
[No Abstract] [Full Text] [Related]
17. Swine influenza: nephrologist's perspective.
Gupta A; Ignatius A; Khaira A; Agarwal SK
Iran J Kidney Dis; 2009 Jul; 3(3):175-6. PubMed ID: 19617670
[No Abstract] [Full Text] [Related]
18. Antiviral research - 20th International Conference.
Oni A
IDrugs; 2007 Jul; 10(7):453-4. PubMed ID: 17642013
[No Abstract] [Full Text] [Related]
19. FDA notifications. EUA issued for treating novel 2009 H1N1 flu.
AIDS Alert; 2009 Jun; 24(6):69-70. PubMed ID: 19544608
[No Abstract] [Full Text] [Related]
20. [Influenza with virus A/H1N1: questions and answers].
OMS/CDC
Ig Sanita Pubbl; 2009; 65(2):157-68. PubMed ID: 19606577
[No Abstract] [Full Text] [Related]
[Next] [New Search]
